Gene Sculpt Suite

Gene Sculpt Suite provides computational tools to design oligonucleotides and predict microhomology-mediated DNA repair outcomes to improve precision of genome editing with Zinc Finger Nucleases, TALENs, and CRISPR/Cas systems.


Key Features:

  • GTagHD: Automates the design and generation of oligonucleotides tailored for the GeneWeld knock-in protocol.
  • MEDJED: Employs machine learning to predict the likelihood that a double-stranded DNA break will engage the microhomology-mediated repair (MMR) pathway.
  • MENTHU: Identifies genomic loci likely to yield a single predominant microhomology-mediated end joining allele (PreMA) and predicts the specific repair products following DNA breaks.
  • Supported nucleases: Provides design and prediction capabilities applicable to Zinc Finger Nucleases, TALENs, and CRISPR/Cas systems.

Scientific Applications:

  • Functional genomics: Facilitates targeted perturbations and precise knock-ins to study gene function via predicted repair outcomes and oligonucleotide designs.
  • Therapeutic gene editing: Supports design choices that influence repair pathway usage and allele outcomes relevant to therapeutic gene modification strategies.
  • Synthetic biology: Enables precise insertion and predictable repair outcomes for engineering genetic constructs and pathways.

Methodology:

Automated oligonucleotide design for the GeneWeld knock-in protocol; machine learning–based prediction of MMR engagement at double-stranded breaks; identification and prediction of PreMA microhomology-mediated end joining outcomes.

Topics

Details

License:
GPL-3.0
Maturity:
Mature
Cost:
Free of charge
Tool Type:
web application, workflow
Operating Systems:
Linux, Windows, Mac
Programming Languages:
JavaScript
Added:
8/9/2019
Last Updated:
6/16/2020

Operations

Publications

Mann CM, Martínez-Gálvez G, Welker JM, Wierson WA, Ata H, Almeida MP, Clark KJ, Essner JJ, McGrail M, Ekker SC, Dobbs D. The Gene Sculpt Suite: a set of tools for genome editing. Nucleic Acids Research. 2019;47(W1):W175-W182. doi:10.1093/nar/gkz405. PMID:31127311. PMCID:PMC6602503.

PMID: 31127311
PMCID: PMC6602503
Funding: - National Institutes of Health: GM63904, R24 OD020166